Macula Thickening Clinical Trial
| NCT number | NCT00433225 |
| Other study ID # | 5293 |
| Secondary ID | |
| Status | Completed |
| Phase | Phase 4 |
| First received | February 7, 2007 |
| Last updated | September 5, 2007 |
| Verified date | September 2007 |
| Source | Innovative Medical |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Interventional |
The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.
| Status | Completed |
| Enrollment | 0 |
| Est. completion date | |
| Est. primary completion date | |
| Accepts healthy volunteers | |
| Gender | Both |
| Age group | 50 Years and older |
| Eligibility |
Inclusion Criteria: - Males or females > 50 years old - Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL. - Likely to complete all study visits and able to provide informed consent - Visual potential of 20/25 or better Exclusion Criteria: - ยท Prior use of topical ketorolac - Known contraindications to any study medication or ingredients - Active ocular diseases or uncontrolled systemic disease - Active ocular allergies |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind
| Country | Name | City | State |
|---|---|---|---|
| United States | Ophthalmic Consultants of Long Island | Rockville Centre | New York |
| Lead Sponsor | Collaborator |
|---|---|
| Innovative Medical |
United States,